UK markets close in 6 hours 51 minutes

Edwards Lifesciences Corporation (EW)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
118.26-2.20 (-1.83%)
At close: 04:00PM EST
118.26 0.00 (0.00%)
After hours: 05:36PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 76.07B
Enterprise value 74.96B
Trailing P/E 52.29
Forward P/E 47.39
PEG ratio (5-yr expected) 2.56
Price/sales (ttm)15.15
Price/book (mrq)13.73
Enterprise value/revenue 14.71
Enterprise value/EBITDA 56.15

Trading information

Stock price history

Beta (5Y monthly) 1.09
52-week change 334.52%
S&P500 52-week change 322.74%
52-week high 3131.73
52-week low 378.44
50-day moving average 3119.54
200-day moving average 3109.27

Share statistics

Avg vol (3-month) 32.36M
Avg vol (10-day) 32.16M
Shares outstanding 5624.33M
Implied shares outstanding 6N/A
Float 8619.15M
% held by insiders 10.74%
% held by institutions 185.68%
Shares short (30 Dec 2021) 46.08M
Short ratio (30 Dec 2021) 42.31
Short % of float (30 Dec 2021) 40.98%
Short % of shares outstanding (30 Dec 2021) 40.97%
Shares short (prior month 29 Nov 2021) 45.75M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 331 May 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021


Profit margin 29.00%
Operating margin (ttm)31.10%

Management effectiveness

Return on assets (ttm)13.24%
Return on equity (ttm)30.30%

Income statement

Revenue (ttm)5.09B
Revenue per share (ttm)8.18
Quarterly revenue growth (yoy)14.80%
Gross profit (ttm)3.31B
Net income avi to common (ttm)1.48B
Diluted EPS (ttm)2.33
Quarterly earnings growth (yoy)4.60%

Balance sheet

Total cash (mrq)1.79B
Total cash per share (mrq)2.88
Total debt (mrq)684.1M
Total debt/equity (mrq)12.35
Current ratio (mrq)3.64
Book value per share (mrq)8.88

Cash flow statement

Operating cash flow (ttm)1.76B
Levered free cash flow (ttm)951.77M